Edition:
India

Evolus Inc (EOLS.OQ)

EOLS.OQ on NASDAQ Stock Exchange Global Market

16.96USD
16 Jul 2019
Change (% chg)

$0.97 (+6.07%)
Prev Close
$15.99
Open
$15.96
Day's High
$16.97
Day's Low
$15.89
Volume
114,263
Avg. Vol
199,484
52-wk High
$30.25
52-wk Low
$10.29

About

Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address... (more)

Overall

Beta: --
Market Cap(Mil.): $437.69
Shares Outstanding(Mil.): 27.37
Dividend: --
Yield (%): --

Financials

FDA approves cheaper Botox rival to treat frown lines

(This Feb. 1 story has been corrected to remove reference to dosage in paragraph 7)

04 Feb 2019

CORRECTED-UPDATE 1-FDA approves cheaper Botox rival to treat frown lines (Feb.1)

Feb 1 An injection to treat forehead wrinkles is set to rival Allergan's Botox after U.S. regulators approved Evolus Inc's cheaper treatment on Friday, sending its shares up about 5 percent after the bell.

04 Feb 2019

Earnings vs. Estimates